-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Neumora Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2022 to Q2 2024.
- Neumora Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $5.25M, a 49.1% increase year-over-year.
- Neumora Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $21M.
- Neumora Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $16.4M, a 231% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)